Nasal epithelial cell (NEC (occasionally used in research contexts))

Nasal epithelial cells form the lining of the nasal cavity and constitute an essential part of the respiratory system’s first line of defense. They create both a physical and immune barrier against inhaled pathogens, allergens, and irritants. These cells participate in mucociliary clearance—moving mucus with trapped particles toward the throat—and secrete various cytokines and chemokines that regulate local immune responses. The nasal epithelium is involved in filtering air, humidifying inhaled gases, protecting underlying tissues from infection or injury, and contributing to innate immunity through secretion of antimicrobial peptides. Damage or dysfunction in these cells is implicated in conditions such as infections (viral/bacterial/fungal), chronic inflammation like rhinosinusitis, allergic reactions, and other airway diseases[1][2][3][4]. Note: “Nasal epithelial cell” refers to a heterogeneous population of structural/functional units within tissue—not to a single protein/gene/molecular target typically considered “druggable.” Therefore it is not classified as a therapeutic target such as an enzyme or receptor. For structured drug discovery information you would need to specify particular molecules expressed on/in these cells—such as ion channels (CFTR), transporters (ENaC), mucins (MUC5AC/MUC5B), or pattern recognition receptors. If you require information about specific molecular targets within nasal epithelium relevant for therapy development—such as TMEM16A chloride channel or CFTR—please specify further.

Other names

Nasal epithelium cellRespiratory epithelial cell (nasal)NEC (rarely)